Zdrowie i gospodarka · 21/01/2022
FDA Classifies Retinal Diagnostic Software Device into Class II with Special Controls
The FDA has classified the retinal diagnostic software device into Class II with special controls, aiming to ensure its safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →